Literature DB >> 12589786

Sequence analysis, expression, and paratope characterization of a single-chain Fv fragment for the eukaryote ribosomal P proteins.

Pablo López Bergami1, Pablo Mateos, Johan Hoebeke, Mariano Jorge Levin, Alberto Baldi.   

Abstract

The variable genes of monoclonal antibody (mAb) B10, specific for the C-terminal region of the eukaryotic ribosomal P protein, have been cloned as a single-chain Fv fragment (scFv) and expressed in Escherichia coli. The primary sequence of the variable regions of the B10 antibody, together with a detailed characterization of the reactive residues of the antigen, allowed the construction of a model of the paratope-epitope interaction, giving a first insight into the binding mechanisms of anti-P autoantibodies to their target peptides. The mAb and scFv could be useful for extensive P protein detection since both recognize the highly conserved motif DDxGF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12589786     DOI: 10.1016/s0006-291x(02)03074-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Problems in using statistical analysis of replacement and silent mutations in antibody genes for determining antigen-driven affinity selection.

Authors:  Biplab Bose; Subrata Sinha
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

2.  Selective blockade of trypanosomatid protein synthesis by a recombinant antibody anti-Trypanosoma cruzi P2β protein.

Authors:  Maximiliano Juri Ayub; Benson Nyambega; Leandro Simonetti; Tomas Duffy; Silvia A Longhi; Karina A Gómez; Johan Hoebeke; Mariano J Levin; Cristian R Smulski
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

3.  Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis.

Authors:  Soledad Matus; Patricia V Burgos; Marcela Bravo-Zehnder; Regine Kraft; Omar H Porras; Paula Farías; L Felipe Barros; Fernando Torrealba; Loreto Massardo; Sergio Jacobelli; Alfonso González
Journal:  J Exp Med       Date:  2007-12-03       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.